Published in Cold Spring Harb Symp Quant Biol on January 01, 1998
The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev (2000) 3.71
Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet (2007) 3.24
Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci U S A (2003) 2.63
Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J (2002) 2.49
The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev (2005) 2.29
Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc Natl Acad Sci U S A (2002) 2.12
Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J (2001) 1.91
A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol Cell Biol (2000) 1.90
Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc Natl Acad Sci U S A (2001) 1.80
Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. Mol Cell Biol (2003) 1.76
Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc Natl Acad Sci U S A (2003) 1.60
A small conserved surface in SUMO is the critical structural determinant of its transcriptional inhibitory properties. Mol Cell Biol (2005) 1.40
Identification of C. elegans DAF-12-binding sites, response elements, and target genes. Genes Dev (2004) 1.39
Combinatorial gene control involving E2F and E Box family members. EMBO J (2004) 1.35
Distinctions in the specificity of E2F function revealed by gene expression signatures. Proc Natl Acad Sci U S A (2005) 1.34
The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals. Nat Struct Mol Biol (2013) 1.31
CCAAT/Enhancer-binding protein beta DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CREB-binding protein (CBP). J Biol Chem (2010) 1.08
A genome-wide signature of glucocorticoid receptor binding in neuronal PC12 cells. BMC Neurosci (2012) 1.04
Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. Proc Natl Acad Sci U S A (2000) 1.00
A combinatorial mechanism for determining the specificity of E2F activation and repression. Oncogene (2009) 0.94
Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening. Proc Natl Acad Sci U S A (2009) 0.93
Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle. Proc Natl Acad Sci U S A (2013) 0.91
The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA). DNA Cell Biol (2002) 0.91
Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation. Biologics (2008) 0.87
Incoherent feed-forward regulatory logic underpinning glucocorticoid receptor action. Proc Natl Acad Sci U S A (2013) 0.86
Preparing the first responders: building the inflammatory transcriptome from the ground up. Mol Cell (2014) 0.86
Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain. Steroids (2009) 0.84
TBP binding-induced folding of the glucocorticoid receptor AF1 domain facilitates its interaction with steroid receptor coactivator-1. PLoS One (2011) 0.84
Effects of different osmolytes on the induced folding of the N-terminal activation domain (AF1) of the glucocorticoid receptor. Arch Biochem Biophys (2007) 0.83
Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting. Asian J Androl (2016) 0.77
Bifunctional ligands allow deliberate extrinsic reprogramming of the glucocorticoid receptor. Mol Endocrinol (2014) 0.76
Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma. Nucl Recept Signal (2015) 0.75
Ligand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancy. Biochem Biophys Res Commun (2012) 0.75
Gain-of-Function Alleles in Caenorhabditis elegans Nuclear Hormone Receptor nhr-49 Are Functionally Distinct. PLoS One (2016) 0.75
Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol (2017) 0.75
Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev (1998) 5.28
Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science (1998) 2.31
Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J (1999) 2.24
Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med (1984) 2.16
Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell (1999) 2.01
Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun (2001) 1.74
Microlaryngoscopic surgery for T1 glottic lesions: a cost-effective option. Ann Otol Rhinol Laryngol (1994) 1.55
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
The role of hemilaryngectomy in the management of T1 vocal cord cancer. Arch Otolaryngol Head Neck Surg (1989) 1.40
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology (1984) 1.24
The catalytic mechanism of indole-3-glycerol phosphate synthase: crystal structures of complexes of the enzyme from Sulfolobus solfataricus with substrate analogue, substrate, and product. J Mol Biol (2002) 1.15
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Infection following uncontaminated head and neck surgery. Arch Otolaryngol Head Neck Surg (1987) 1.10
Cancer of the tongue in patients less than forty. Head Neck (2000) 1.10
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
A conformational switch in the ligand-binding domain regulates the dependence of the glucocorticoid receptor on Hsp90. J Mol Biol (2007) 1.07
Molecular and structural biology of thyroid hormone receptors. Clin Exp Pharmacol Physiol Suppl (1998) 1.06
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis (1987) 1.03
Prognostic factors in mobile tongue and floor of mouth carcinoma. Cancer (1989) 1.03
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors. J Biol Chem (1999) 1.00
Observation of Bs(0)-Bs(0) oscillations. Phys Rev Lett (2006) 1.00
DAX1 mutations map to putative structural domains in a deduced three-dimensional model. Am J Hum Genet (1998) 0.99
The molecular biology of thyroid hormone action. Ann N Y Acad Sci (1995) 0.99
Antibiotic prophylaxis in high-risk head and neck surgery: one-day vs. five-day therapy. Otolaryngol Head Neck Surg (1986) 0.98
Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol Metab (2001) 0.97
Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97
Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96
Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies. Recent Prog Horm Res (1998) 0.95
Lipid and volume analysis of neck drainage in patients undergoing neck dissection. Am J Otolaryngol (1993) 0.95
Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys Rev Lett (2007) 0.95
Measurement of the strong coupling constant from inclusive jet production at the Tevatron pp collider. Phys Rev Lett (2002) 0.94
X-ray crystallographic and functional studies of thyroid hormone receptor. J Steroid Biochem Mol Biol (1998) 0.93
Search for gluinos and scalar quarks in pp collisions at square root[s] = 1.8 TeV using the missing energy plus multijets signature. Phys Rev Lett (2002) 0.93
Search for a fermiophobic Higgs boson decaying into diphotons in pp[over] collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2009) 0.92
First measurement of the b-jet cross section in events with a W boson in pp collisions at square root(s) = 1.96 TeV. Phys Rev Lett (2010) 0.91
Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 0.91
Neuropathological studies of schizophrenia: a selective review. Schizophr Bull (1983) 0.90
Search for Z' --> e+ e- using dielectron mass and angular distribution. Phys Rev Lett (2006) 0.90
The efficacy of perioperative antibiotic therapy on recovery following tonsillectomy in adults: randomized double-blind placebo-controlled trial. Otolaryngol Head Neck Surg (1992) 0.89
Medial vs lateral wall pyriform sinus carcinoma: implications for management of regional lymphatics. Head Neck (1994) 0.89
Measurements of the angular distributions in the decays B→K(*)μ(+)μ(-) at CDF. Phys Rev Lett (2012) 0.88
Posterior nasal packing. Are intravenous antibiotics really necessary? Arch Otolaryngol Head Neck Surg (1989) 0.88
Evidence for B0 s-->phiphi decay and measurements of branching ratio and A(CP) for B+ -->phiK+. Phys Rev Lett (2005) 0.87
Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor. J Biol Chem (2001) 0.87
Search for top-quark production via flavor-changing neutral currents in W+1 jet events at CDF. Phys Rev Lett (2009) 0.87
Inclusive search for squark and gluino production in pp[over ] collisions at sqrt[s]=1.96 TeV. Phys Rev Lett (2009) 0.87
Search for the flavor-changing neutral-current decay t-->Zq in pp collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2008) 0.86
Search for anomalous production of multilepton events in pp collisions at sqrt s=1.96 TeV. Phys Rev Lett (2007) 0.86
Prophylactic antibiotics for head and neck surgery with flap reconstruction. Arch Otolaryngol Head Neck Surg (1992) 0.86
The use of a computer-based decision support system facilitates primary care physicians' management of chronic pain. Anesth Analg (2001) 0.86
A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck. Cancer (1996) 0.86
Bacteriologic analysis of wound infection following major head and neck surgery. Arch Otolaryngol Head Neck Surg (1988) 0.86
The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125. Arch Otolaryngol Head Neck Surg (1992) 0.85
Search for new high-mass particles decaying to Lepton pairs in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2005) 0.85
Tardive dystonia in a psychiatric hospital. J Neurol Neurosurg Psychiatry (1987) 0.85
Development of quality control methodology for new drugs. Bull Parenter Drug Assoc (1972) 0.85
Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients. Head Neck (1995) 0.85
Search for the standard model Higgs Boson produced in association with top quarks using the full CDF data set. Phys Rev Lett (2012) 0.85
Outcome of open surgical therapy for glottic carcinoma. Ann Otol Rhinol Laryngol (1993) 0.85
Exogenous acetate reconstitutes the enzymatic activity of trypsin Asp189Ser. Biochemistry (1994) 0.85
Search for dark matter in events with one jet and missing transverse energy in pp¯ collisions at √s=1.96 TeV. Phys Rev Lett (2012) 0.84
Analysis of the quantum numbers J(PC) of the X(3872) particle. Phys Rev Lett (2007) 0.83
Search for Higgs bosons predicted in two-Higgs-doublet models via decays to tau lepton pairs in 1.96 TeV pp collisions. Phys Rev Lett (2009) 0.83
Multiple promoter elements govern expression of the human ornithine decarboxylase gene in colon carcinoma cells. Nucleic Acids Res (1992) 0.83
Measurement of the forward-backward asymmetry in the B→K*μ(+)μ(-) decay and first observation of the B(s)0→ϕμ(+)μ(-) decay. Phys Rev Lett (2011) 0.83
Ventricular elastic modulus as a function of age in the Syrian golden hamster. Circ Res (1976) 0.83
SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck. Laryngoscope (1989) 0.83
Search for supersymmetry in pp collisions at sqrt[s]=1.96 TeV Using the trilepton signature for chargino-neutralino production. Phys Rev Lett (2008) 0.83
Combination of Tevatron searches for the standard model Higgs boson in the W+W- decay mode. Phys Rev Lett (2010) 0.83
Forward-backward asymmetry in top-quark production in pp[over] collisions at sqrt[s]=1.96 TeV. Phys Rev Lett (2008) 0.82
Search for B(s)(0) → μ+ μ- and B(0) → μ+ μ- decays with CDF II. Phys Rev Lett (2011) 0.82
Search for the production of narrow tb[over] resonances in 1.9 fb;{-1} of pp[over] collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2009) 0.82
Search for neutral Higgs bosons of the minimal supersymmetric standard model decaying to tau pairs in pp collisions at square root of s = 1.96 TeV. Phys Rev Lett (2006) 0.82
Some properties of beta-glucuronidase activity in normal rat liver and in several transplantable rat hepatomas. Cancer Res (1967) 0.82
Supraglottic carcinoma: patterns of recurrence. Ann Otol Rhinol Laryngol (1990) 0.82
Transmandibular approaches to the oral cavity and oropharynx. A functional assessment. Arch Otolaryngol Head Neck Surg (1992) 0.82
Etiologic factors in head and neck wound infections. Laryngoscope (1987) 0.81
Precision top-quark mass measurement in the lepton+jets topology in p p collisions at square root s=1.96 TeV. Phys Rev Lett (2006) 0.81
Observation of the baryonic flavor-changing neutral current decay Λb(0)→Λμ+μ-. Phys Rev Lett (2011) 0.81
Search for [corrected] B0(s) --> mu+ mu- and B0(d) [corrected] --> mu + mu- decays in pp collisions with CDF II. Phys Rev Lett (2005) 0.81
Akathisia: the syndrome of motor restlessness. Am Fam Physician (1987) 0.80
Search for B0s-->micro+micro- and B0d-->micro+micro- decays in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2004) 0.80
Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes. J Neurochem (1994) 0.80
Observation of electroweak single top-quark production. Phys Rev Lett (2009) 0.80
Superiority of the T and N integer score (TANIS) staging system for squamous cell carcinoma of the oral cavity. Otolaryngol Head Neck Surg (1995) 0.79
Neuroleptic malignant syndrome. The results of a 6-month prospective study of incidence in a state psychiatric hospital. Clin Neuropharmacol (1988) 0.79
Role of prophylactic antibiotics in uncontaminated neck dissections. Arch Otolaryngol Head Neck Surg (1991) 0.79
Regulation of ornithine decarboxylase mRNA levels in human breast cancer cells: pattern of expression and involvement of core enhancer promoter element. Cell Growth Differ (1995) 0.79
Cefazolin vs moxalactam? A double-blind randomized trial of cephalosporins in head and neck surgery. Arch Otolaryngol Head Neck Surg (1986) 0.79
The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction. Laryngoscope (2001) 0.78
A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation. Mol Endocrinol (1998) 0.78
Free jejunal transfer for reconstruction of the laryngopharynx. Otolaryngol Head Neck Surg (1987) 0.78
Observation of the narrow state X(3872)-->J/psipi+pi- in pp collisions at sqaure root of s=1.96 TeV. Phys Rev Lett (2004) 0.78